A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors

Clinical trial NCT06632574 · RECRUITING

Trial details

NCT number: NCT06632574
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2014-03-19
Primary completion: 2025-10-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.